Executive Medical Director, SERM

Sarepta Therapeutics; Cambridge (MA); Hybrid; USD 313,000 - 392,000; Full time

Benefits offered by this job

Physical and Emotional Wellness

Financial Wellness

Support for Caregivers

Job summary

Sarepta Therapeutics is seeking an Executive Medical Director, SERM to provide leadership for safety scientists and safety physicians in the SERM group. You will own safety, pharmacovigilance, and risk management activities across investigational and marketed products.

You will collaborate with cross-functional teams in a matrix environment, drive medical safety oversight in trials, and contribute to risk management and REMS programs.

Qualifications

• MD with knowledge and clinical practice in General Medicine.
• 7+ years pharmacovigilance experience.
• Experience in safety reviews of clinical safety data and regulatory documents (AEs/SAEs, IBs, protocols, CSR, safety submissions).
• Ability to communicate and collaborate effectively in a matrix environment.

Responsibilities

• Represent PV & RM in clinical development projects providing expert medical guidance on safety matters for investigational products.
• Communicate safety alerts/signals, risk management plans, reference safety information and safety evaluations of emergent safety issues.
• Provide medical safety oversight in clinical trials.
• Lead protocol development for safety data collection, monitoring of safety data, and review of AEs/SAEs.
• Contribute to periodic safety reports (DSUR, EAP, PBRER) and safety governance.
• Lead REMS content development and safety risk management plans.

Skills

Pharmacovigilance

Safety oversight

Medical communication

Clinical safety data review

Multi-tasking

Education

MD / Doctor of Medicine

Job description

Why Sarepta? Why Now?

The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients.

What Sarepta Offers

At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas:

• Physical and Emotional Wellness
• Financial Wellness
• Support for Caregivers

For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us

The Importance of the Role

The Executive Medical Director, SERM will provide leadership for safety scientists and/or safety physicians in the SERM group. This individual will be accountable for safety, pharmacovigilance, and risk management activities for assigned investigational and marketed products. The Executive Medical Director, SERM will function in a company matrix team environment interacting with several key stakeholder groups including Nonclinical, Research, Clinical Development, Clinical Operations, Biometrics, Medical Affairs, Regulatory Affairs, Quality Assurance, and Commercial.

The Opportunity to Make a Difference

• Representing PV & RM in clinical development projects providing expert medical guidance on safety matters for investigational products.
• Responsible for communicating or producing safety alerts/signals, development risk management plans, reference safety information and safety evaluations of emergent safety issues.
• Provides medical safety oversight in clinical trials.
• Participates in protocol development, specifically the collection and monitoring of safety data in interventional and observational studies, medical review of adverse events/SAEs and evaluation of safety data and statistical analysis planning and reporting of study data.
• Contributes to preparation and review of periodic safety reports (DSUR, EAP Reports)
• Contributes to activities of DSMBs and safety events adjudication committees.
• Contributes to analysis of safety data from on-going and completed studies and their representation in clinical study reports.
• Provides leadership for IB section “Guidance for Investigators” and other safety sections.
• Provides leadership on clinical safety content of country marketing applications e.g. NDA/MAA Clinical Safety Summary and REMS/Risk Management Plan.
• Performs medical review oversight for individual case safety reports (ICSRs) from post-marketing sources.
• Leads product risk management strategy and facilitates production and maintenance of risk management plans.
• Participates in the signal management system with regular review of safety data for assigned products and detection and evaluation of new safety signals.
• Provides medical input to design and maintenance of REMS programs, monitoring of REMS goals and provision of REMS Assessment Reports.
• Leads benefit-risk discussions at the safety governance committee and implementation of risk minimization actions.
• Conducts medical evaluation of relevant safety-related information from toxicology, non-clinical studies, as well as product quality complaints, as needed.
• Contributes to preparation and review of periodic safety reports (FDA Enhanced PV Plan Report, PBRER).
• Provides leadership for the safety physicians and safety scientists in the SERM group.
• Participates in leadership oversight of safety vendors and provides back-up for the Head of PV & RM.
• Participates in continuous improvement activities of self as well as for PV & RM department including systems design and quality management activities.
• Contributes to development of the PV & RM department via involvement in recruiting/coaching talent and fiscal management.

More about You

M.D. with solid knowledge and clinical practice experience of General Medicine. Experience in medical safety activities within PV for products in clinical trials and in post marketing is required. 7+ years pharmacovigilance experience. Competent in safety reviews of clinical safety data/documents including AEs/SAEs, IBs, protocols, clinical study reports and informed consent documents and safety submissions (CTD clinical safety summary). Competent in safety reviews of postmarketing safety documents including spontaneous reports and other individual case safety reports (ICSRs), periodic safety reports, risk management plans, company core data sheet Knowledge of GVP, GCP, ICH guidance and safety regulations. Ability to communicate and collaborate effectively in a matrix environment. Excellent written and oral communication skills. Good judgment and decision-making skills, including identification and communication of relevant safety-related issues or concerns to PV & RM Management in an appropriate and timely manner. Ability to multi-task. Close attention to detail

This position is hybrid, you will be expected to work on site at one of Sarepta’s facilities in the United States and/or attend Company-sponsored in-person events from time to time.

The targeted salary range for this position is $313,200 - $391,500 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity.

Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify.

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. Our deep pipeline is driven by our multi-platform technologies in siRNA, RNA and gene therapy. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.